|
Status |
Public on Sep 02, 2021 |
Title |
7 caki cl2a_(miRNA-4_0) |
Sample type |
RNA |
|
|
Source name |
ccRCC Caki sunitinib resistant cell line
|
Organism |
Homo sapiens |
Characteristics |
cell line: Caki-1 cell type: clear cell renal cell carcinoma (ccRCC) drug resistance: sunitinib resistant
|
Treatment protocol |
Sunitinib concentrations were increased incrementally by 0.5uM steps until the IC50 values reached >10uM
|
Growth protocol |
cells were grown over several months either with sunitinib (two clones per cell line) or without (parental cell lines).
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA was extracted for cells with Trizol using standard protocols
|
Label |
biotin
|
Label protocol |
standard Affymetrix protocol
|
|
|
Hybridization protocol |
standard Affymetrix protocol
|
Scan protocol |
standard Affymetrix protocol
|
Description |
miRNA expression data from clone 2 of Caki sunitinib resistant ccRCC cell line
|
Data processing |
RMA processed in affymetrix TAC (v.4.0.2)
|
|
|
Submission date |
Aug 31, 2021 |
Last update date |
Sep 03, 2021 |
Contact name |
charles lawrie |
E-mail(s) |
charles.lawrie@biodonostia.org
|
Phone |
0622080463
|
Organization name |
Biodonostia Research Institute
|
Department |
Oncology
|
Street address |
Paseo Mikeletegi, 83- planta 3
|
City |
Donsotia-San Sebastian |
ZIP/Postal code |
20012 |
Country |
Spain |
|
|
Platform ID |
GPL30571 |
Series (1) |
GSE183140 |
Integrated miRNA-genomic analysis of sunitinib resistance in clear cell renal cell carcinoma (CCRCC) cell lines |
|